Химакс Фарма еоод restarta capsules 330 mg (Valerian root 56 mg/ St. John`s Wort Herb 120 mg) Хранителна добавка от растителен произход

Ahuis, F. 1998. Neues ber Johanniskraut [News on St. John's Wort]. Deutsche Apotheker Zeitung138:17831785.

BfArM. 1998. Meeting of BfArM, Johanniskraut, No. 113. BPI [Federal Manufacturers Association]. 151.

Bhattacharya, S.K., A. Chakrabarti, S.S. Chatterjee. 1998. Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models. Pharmacopsychiatry 31 (suppl. 1):2229.

Bombardelli, E. and P. Morazzoni. 1995. Hypericum perforatum. Fitoterapia. 66(1):4368.

Brantner, A., T. Kartnig, F. Quehenberger. 1994. Vergleichende phytochemische Untersuchungen anHypericum perforatum L. und Hypericum maculatum Crantz. Sci Pharm 62:261276.

Braun, R. et al. 1997. Standardzulassungen f r FertigarzneimittelText and Kommentar. Stuttgart: Deutscher Apotheker Verlag.

British Herbal Pharmacopoeia (BHP). 1996. Exeter, U.K.: British Herbal Medicine Association.

Bruneton, J. 1995. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing.

B hler. 1995. Communication from BfArM (German Federal Institute of Drugs and Medical Devices to German Nonprescription Drug Association (BAH), Sept. 11.

Bundesanzeiger (BAnz). 1998. Monographien der Kommission E (Zulassungs- und Aufbereitungskommission am BGA f r den humanmed. Bereich, phytotherapeutische Therapierichtung und Stoffgruppe). Kln: Bundesgesundheitsamt (BGA).

Butterweck, V., G. J rgenliemk, A. Nahrstedt, H. Winterhoff. 1999. Flavonoid-Fraktionen und Hyperosid ausHypericum perforatum L. zeigen anti-depressive Aktivitt im Forced Swimming Test nach PORSOLT.Zeitschrift f r Phytotherapie 20:8687.

Chatterjee, S.S., M. Noldner, E. Koch, C. Erdelmeier. 1998. Antidepressant activity of Hypericum perforatumand Hyperforin: the neglected possibility. Pharmacopsychiatry 31 (suppl. 1):715.

Cott, J.M. 1999. Personal communication to M. Blumenthal, Aug. 27.

Cott, J.M. and A. Fugh-Berman. 1998. Is St. John's Wort (Hypericum perforatum) an effective antidepressant? J Nerv Ment Dis 186(8):500501.

Cott, J.M. 1997. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.Pharmacopsychiatry 30 (suppl. 2):108112.

De Smet, P.A. and W.A. Nolen. 1996. St. John's wort as an antidepressant. BMJ 313(7052):241242.

Deutscher Arzneimittel-Codex (DAC). 1986. Stuttgart: Deutscher Apotheker Verlag. J010/15.

Deutscher Arzneimittel-Codex, 3^rd suppl. (DAC). 1991. Stuttgart: Deutscher Apotheker Verlag.

Ellingwood, F. 1983. American Materia Medica, Therapeutics and Pharmacognosy. Portland, OR: Eclectic Medical Publications [reprint of 1919 original].

ESCOP. 1997. 'Hyperici Herba.' Monographs on the Medicinal Uses of Plant Drugs. Exeter, U.K.: European Scientific Cooperative on Phytotherapy.

Felter, H.W. 1985. The Eclectic Materia Medica, Pharmacology and Therapeutics Portland, OR: Eclectic Medical Publications [reprint of the 1922 original]. 424.

Felter, H.W. and J.U. Lloyd. 1983. King's American Dispensatory, 18^th ed., 3^rd rev. Portland, OR: Eclectic Medical Publications [reprint of 1898 original]. 10831039.

Fugh-Berman A. and J.M. Cott. 1999. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med (in press, Sept.; Oct.).

Hnsgen, K.D., J. Vesper, M. Ploch. 1994. Multicenter double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. J Geriatr Psychiatr Neurol 7(suppl. 1):S15S18.

Hobbs, C. 1989. St. John's wort: Hypericum perforatum L. A review. HerbalGram 18/19:2433.

H bner, W.D., S. Lande, H. Podzuweit. 1994. Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatr Neurol 7(suppl. 1):S12S14.

Karnick, C.R. 1994. Pharmacopoeial Standards of Herbal Plants, Vols. 12. Delhi: Sri Satguru Publications. Vol. 1:189192; Vol. 2:125.

Kasper, S. 1997. Treatment of seasonal affective disorder (SAD) with Hypericum Extract. Pharmacopsych30:S8993.

King, J. 1866. The American Dispensatory, 7^th ed. Cincinnati: Moore, Wilstach, & Baldwin.

Kneipp, 1996. Wegweiser zu den Kneipp Mitteln [Guide to Kneipp Remedies]. W rzburg: Sebastian Kneipp Gesundheitsmittel-Verlag. 4849, 168, 172.

Kugler, J. W. et al. 1990. Therapie depressiver Zustnde. Hypericum-Extrakt Steigerwald als Alternative zur Benzodiazepin-Behandlung. Z Allg Med 66:2129.

Laakmann, G., A. Deniel, M. Kieser. 1998a. Clinical significance of Hyperforin for the efficacy of Hypericumextracts on depressive disorders of different severities. Phytomedicine 5(6):435442.

Laakmann, G., C. Schule, T. Baghai, M. Kieser. 1998b. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31(suppl. 1):5459.

Lange, D. and U. Schippmann. 1997. Trade Survey of Medicinal Plants in GermanyA Contribution to International Plant Species Conservation. Bonn: Bundesamt f r Naturschutz. 2935.

Leung, A.Y. and S. Foster. 1996. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2^nd ed. New York: John Wiley & Sons, Inc.

Linde, K. et al. 1996. St. John's wort for depressionan overview and meta-analysis of randomised clinical trials. BMJ 313(7052):253258.

McGuffin, M., C. Hobbs, R. Upton, A. Goldberg. 1997. American Herbal Product Association's Botanical Safety Handbook. Boca Raton: CRC Press.

Meyer-Buchtela, E. 1999. Tee-RezepturenEin Handbuch f r Apotheker und rzte. Stuttgart: Deutscher Apotheker Verlag.

Nadkarni, K.M. 1976. Indian Materia Medica. Bombay: Popular Prakashan. 673.

Newall, C.A., L.A. Anderson, J.D. Phillipson. 1996. Herbal Medicines: A Guide for Health-Care Professionals.London: The Pharmaceutical Press.

Okpanyi, S.N. and M.L. Weischer. 1987. Tierexperimentelle untersuchungen zur psychotropen wirksamkeit eines Hypericum-extraktes [Animal experiments on the psychotropic action of a Hypericum extract].Arzneimittelforschung 37:1013.

Pickering, C. 1879. Chronological History of Plants. Boston: Little Brown & Co.

Rasmussen, P. 1998. St. John's wortA review of its use in depression. Australian J Med Herbalism 10(1):813.

Reuter, H.D. 1995. St. John's wort as a herbal antidepressant. Eur J Herbal Med Part I:1(3):1924; Part II:1(4):1521.

. 1998. In: Lawson, L.D. and R. Bauer (eds.). 1998. Phytomedicines of EuropeChemistry and Biological Activity. Washington, D.C.: American Chemical Society. 287298.

Reynolds, J.E.F. (ed.). 1993. Martindale: The Extra Pharmacopoeia, 30^th ed. London: The Pharmaceutical Press.

Schilcher, H. 1997. Phytotherapy in PediatricsHandbook for Physicians and Pharmacists. Stuttgart: Medpharm Scientific Publishers. 6162.

Schulz, V. 1998. Hyperforin values: By no means just 'traces.' [letter]. Deutsche Apotheker Zeitung 138(6).

Schulz, V., W.D. H bner, M. Ploch. 1997. Clinical trials with phyto-psychopharmacological agents. Phytomed4(4):379387.

Schulz, H. and M. Jobert. 1993. Der Einfluss von Johanniskraut-Extrakt auf das Schlaf-EEG bei lteren Probandinnen. Nervenheilkunde 12:323327.

Schulz, V., R. Hnsel, V.E. Tyler. 1998. Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. New York: Springer. 5065.

Staffeldt, B. et al. 1993. Pharmakokinetik von Hypericin und Pseudohypericin nach oraler Einnahme des Johanniskraut-Extraktes LI 160 bei gesunden Probanden. Nervenheilkunde 12:331338.

Snow, J.M. 1996. Hypericum perforatum L. (Hyperiaceae). Protocol J Botanical Med 2(1):1621.

State Pharmacopoeia of the Union of Soviet Socialist Republics, 10^th ed. (USSR X). 1973. Moscow: Ministry of Health of the U.S.S.R.

Upton, R. (ed.). 1997. St. John's Wort (Hypericum perforatum). American Herbal Pharmacopoeia (AHP). Santa Cruz: American Herbal Pharmacopoeia. 132 (published in HerbalGram 40).

USP-DI Update. 1998. St. John's Wort and Powdered St. John's Wort. Rockville, MD: United States Pharmacopeia Convention, May.

USP. 1999a. St. John's Wort and Powdered St. John's Wort. United States Pharmacopeia 24National Formulary 19. Rockville, MD: United States Pharmacopeia Convention, Inc.

USP. 1999b. Powdered St. John's wort extract monograph. Pharmacopeial Forum 25(2).

USSR X. See State Pharmacopoeia of the Union of Soviet Socialist Republics.

Weiser, D. 1991. Pharmakokinetik von Hypericin nach oraler Einnahme des Johanniskraut-Extraktes LI 160.Nervenheilkunde 10:318319.

Wichtl, M. and N.G. Bisset (eds.). 1994. Herbal Drugs and Phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers.

Wonnemann, M., C. Schfer, W.E. M ller. 1999. Johanniskrautextrakt: Effekte auf GABA- und glutamaterge Rezeptorsysteme. Zeitschrift f r Phytotherapie 20:7782.



Additional Resources

British Herbal Pharmacopoeia (BHP).1983. Keighley, U.K.: British Herbal Medicine Association.

Constantine, G.H. and J. Karchesy. 1999. Variations in Hypericin concentrations in Hypericum perforatum L. and commercial products. Pharm Biol 36(5):365367.

Cracchiolo, C. 1998. Pharmacology of St. John's wort: botanical and chemical aspects. Sci Rev Alt Med2(1):2935.

Denke, A., W. Schneider, E.F. Elstner. 1999. Biochemical activities from Hypericum perforatum L.: 2^ndCommunication: Inhibition of metenkphaline- and tyrosine-dimerization. Arzneim-Forsch/Drug Res49(2):109114.

Denke, A., H. Schempp, E.Mann, W. Schneider, E.F. Elstner. 1999. Biochemical activities from Hypericum perforatum L.: 4^th communication: Influence of different cultivation methods. Arzneimforsch/Drug Res49(2):120125.

Erdelmeier, C.A. 1998. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsych 31(suppl. 1):26.

Gaedcke, F. 1997. Johanniskraut und dessen Zubereitungen. Deut Apoth Zeit No. 42/97.

Grush, L.R., A. Nierenberg, B. Keefe, L.S. Cohen. 1998. St. John's wort during pregnancy [letter]. JAMA280:1566.

Halama, P. 1991. Wirksamkeit des HypericumExtraktes LI 160 bei 50 Patienten einer psychiatrischen Fachpraxis. Nervenheilkunde 10:305307.

Hnsel, R., K. Keller, H. Rimpler, G. Schneider (eds.). 1993. Hagers Handbuch der Pharmazeutischen Praxis, 5^thed. Vol. 5. Berlin-Heidelberg: Springer Verlag. 474495.

Hippius, H. 1998. St John's wort (Hypericum perforatum)A herbal antidepressant. [In process citation]. Curr Med Res Opin 14(3):171184.

Kleber, E., T. Obry, S. Hippeli, W. Schneider, E.F. Elstner. 1999. Biochemical activities of extracts fromHypericum perforatum L. 1^st Communication: Inhibition of dopamine-beta-hydroxylase. Arzneim-Forsch/Drug Research 49(2):106109.

Lust, J. 1974. The Herb Book. New York: Bantam Books. 344.

Martinez, B., S. Kasper, S. Ruhrmann, H.J. Moller. 1994. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol 7(suppl. 1):S29S33.

Mediherb, Pty. Ltd. 1996. HypericumNew uses for an old wort. Mediherb Professional Newsletter Part 1:44, Part 2:45, Part 3:46.

M ller, W.E. et al. 1998. Hyperforin represents the neuro-transmitter reuptake inhibiting constituent ofHypericum extract. Phamacopsych 31(suppl. 1):1621.

M ller, W.E., M. Rolli, C. Schafer, U. Hafner. 1997. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30(suppl.):102107.

Norme Franaise (NF). 1989. NF T 75-348. Paris: Direction des Journaux Officiels.

Reh, C., P. Laux, N. Schenk. 1992. HypericumExtrakt bei Depressioneneine wirksame Alternative.Therapiewoche 42(25):15761581.

Reuter, H.D. 1993. Hypericum als pflanzliches Antidepressivum. Z Phytother 14:239254.

Schellenberg, R., S. Sauer, W. Dimpfel. 1998. Pharmacodynamic effects of two different Hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsych 31 (suppl. 1):4453.

Schemp, H., A.Denke, E.Mann, W. Schneider, E.F. Elstner. 1999. Biochemical Activities from Hypericum perforatum L. 3^rd communication: Modulation of peroxidase activity as a simple method for standardization.Arzneim-Forsch/Drug Res 49(2):115119.

Sharpley, A.L., C.L. McGavin, R. Whale, P.J. Cowen. 1998. Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram. [In Process Citation]. Psychopharmacology(Berl)139(3):286287.

Smyshliaeva, A.V. and IuB Kudriashov. 1992. Modifikatsiia luchevogo porazheniia zhivotnykh vodnym ekstraktom Hypericum perforatum L. Soobshchenie 1 [The modification of a radiation lesion in animals with an aqueous extract of Hypericum perforatum L. 1]. Biol Nauki (4):79.

Sommer, H. 1991. Besserung psychovegetativer Beschwerden durch Hypericum im Rahmen einer multizentrischen Doppelblindstudie. Nervenheilkunde 10:308310.

Vorbach, E.U., K.H. Arnold, W.D. H bner. 1997. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsych30(suppl.):8185.

Wheatley D. 1997. LI 160, an extract of St. John's wort, versus amitriptyline in mild to moderately depressed outpatientsa controlled 6-week clinical trial. Pharmacopsych 30(suppl.):7780.